Filing Details

Accession Number:
0001104659-19-046923
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-22 12:09:04
Reporting Period:
2019-08-20
Accepted Time:
2019-08-22 12:09:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1722964 Y-Mabs Therapeutics Inc. YMAB Pharmaceutical Preparations (2834) 474619612
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1753185 Johan Wedell-Wedellsborg C/O Weco Group A/S
Rungsted Strandvej 113
Rungsted Kyst G7 2960
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-08-20 108,128 $27.42 724,263 No 4 S Indirect By Weco Group A/S
Common Stock Disposition 2019-08-21 60,116 $27.83 664,147 No 4 S Indirect By Weco Group A
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Weco Group A/S
No 4 S Indirect By Weco Group A
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,010,000 Indirect By WG Biotech ApS
Footnotes
  1. Reporting Person is the majority owner of Weco Group A/S and as such has sole voting and dispositive power with respect to such shares.
  2. Reporting Person is the majority owner of WG Biotech ApS and as such has sole voting and dispositive power with respect to such shares.